NCT06109857Recruiting
Bladder Bank (a Prospective Banking Study)
Mayo Clinic
Start Date
7/6/2022
Completion Date
12/1/2027
Summary
This study collects blood and urine samples from patients with bladder cancer to support the development of tests for early detection of bladder cancer.
Detailed Description
PRIMARY OBJECTIVE: I. To establish a biobank of samples (blood and urine) to support the development of non-invasive tests for early detection of bladder cancer. OUTLINE: This is an observational study. Patients undergo blood and urine sample collection and have their medical records reviewed while on study.
Eligibility Criteria
Age Range: 18 years to No maximum
Inclusion Criteria:
* Age \> 18 years
* Patient has undergone office-based evaluation for hematuria \[computed tomography (CT), ultrasound, cystoscopy\]
Exclusion Criteria:
* Patient has known cancer outside of the target cancer 5 years prior to current collection (not including basal cell or squamous cell skin cancers; if patient has not been seen or if information is not available, the patient is eligible)
* Patient has recurrent muscle invasive bladder cancer
* Patient has ever been previously diagnosed with UTUC (upper tract urothelial carcinoma) prior to bladder resection
* Patient has received chemotherapy class drugs for the treatment of non-target origin cancer in the 5 years prior to current collection
* Patient has had any prior radiation therapy to the target lesion prior to current collection
* Patient has had a biopsy to the target organ and/or lesion within 3 days before collection
* Patient has undergone cystectomy or cystoprostatectomy
* Patient has transurethral instrumentation (placement of urinary catheter) within 7 days prior to urine collection
* Patient has had a urinary tract infection within 14 days prior to urine collection
* Patient has chronic indwelling urinary catheter
Interventions
OTHER
Non-Interventional Study
Conditions
Bladder Carcinoma
Locations
Mayo Clinic in Rochester
Rochester, Minnesota 55905
United States